The Antithrombin market is expected to grow from USD 508.17 million in 2022 to USD 769.02 million by 2032, at a CAGR of 4.23% during the forecast period 2023-2032.
Antithrombin is a naturally occurring protein that regulates blood clotting and prevents excessive clot formation. It belongs to a group of proteins known as serine protease inhibitors, or serpins. Antithrombin acts as a potent inhibitor of several clotting factors, particularly thrombin (hence its name), a key enzyme involved in forming blood clots. Antithrombin effectively neutralises their activity by binding to thrombin and other clotting factors, preventing the formation of stable blood clots and maintaining the fluidity of blood within blood vessels.
The rising incidence of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, the rising ageing population and the increasing prevalence of chronic diseases are driving the growth of the antithrombin market. In addition, ongoing research and development efforts in the field of antithrombin are focused on developing novel therapies, including improved recombinant antithrombin and alternative anticoagulant agents. The introduction of innovative products with enhanced efficacy and safety profiles is anticipated to witness significant opportunities during the forecast period. On the other hand, antithrombin products, particularly recombinant antithrombin, can be expensive, limiting their affordability for some patients. The high cost of production, regulatory requirements, and the complexity of manufacturing processes contribute to the elevated prices, which can hamper the market's growth.
This study comprehensively analyses source, application, and region. The source segment includes goat milk, human and others. The goat milk segment held the highest market share in 2022. Goat milk is known to have a naturally high concentration of antithrombin compared to other sources, such as cow milk. The higher antithrombin content in goat milk allows for greater yields during the purification process, reducing production costs and increasing overall efficiency. The application segment is divided into research, therapeutics and diagnostics. The therapeutics segment registered the largest market share in 2022. Antithrombin is crucial in regulating blood clotting, and its deficiency or dysfunction can lead to various thrombotic disorders. A significant and growing patient population requires antithrombin replacement therapies to prevent and treat these conditions. The high demand for antithrombin therapies drives the dominance of the therapeutics segment in the market.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The Asia-Pacific region held the highest market revenue in 2022. The Asia-Pacific region has a significant and growing patient population, contributing to the high demand for antithrombin products. Factors such as large population size, increasing prevalence of chronic diseases, and changing lifestyles contribute to the region's high incidence of thrombotic disorders. The rising and high patient population size drives the region's dominance in the antithrombin market.
Some of the notable players in the market are Lee Biosolutions, Scripps Laboratories, Octapharma AG, LFB USA, rEVO Biologics, Grifols, CSL Ltd., Takeda Pharmaceutical Company Limited, Endpoint Health, Inc., Thermo Fisher Scientific, Siemens Healthcare GmbH and Kedrion among others.
Global Antithrombin Market Analysis and Forecast, Source
Global Antithrombin Market Analysis and Forecast, Application
Global Antithrombin Market Analysis and Forecast, Region
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Source
4.3.2. Market Attractiveness Analysis By Application
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing prevalence of thrombotic disorders
5.3. Restraints
5.3.1. High cost of antithrombin therapies
5.4. Opportunities
5.4.1. Development of novel antithrombin therapies
5.5. Challenges
5.5.1. Potential adverse effects and complication
6. Global Antithrombin Market Analysis and Forecast, By Source
6.1. Segment Overview
6.2. Goat Milk
6.3. Human
6.4. Others
7. Global Antithrombin Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. Research
7.3. Therapeutics
7.4. Diagnostics
8. Global Antithrombin Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Antithrombin Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Antithrombin Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Lee Biosolutions
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Scripps Laboratories
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Octapharma AG
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. LFB USA
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. rEVO Biologics
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Grifols
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. CSL Ltd.
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Takeda Pharmaceutical Company Limited
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Endpoint Health, Inc.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Thermo Fisher Scientific
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. Siemens Healthcare GmbH
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. Kedrion
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
List of Table
1. Global Antithrombin Market, By Source, 2019-2032 (US Million)
2. Global Goat Milk, Antithrombin Market, By Region, 2019-2032 (US Million)
3. Global Human, Antithrombin Market, By Region, 2019-2032 (US Million)
4. Global Others, Antithrombin Market, By Region, 2019-2032 (US Million)
5. Global Antithrombin Market, By Application, 2019-2032 (US Million)
6. Global Research, Antithrombin Market, By Region, 2019-2032 (US Million)
7. Global Therapeutics, Antithrombin Market, By Region, 2019-2032 (US Million)
8. Global Diagnostics, Antithrombin Market, By Region, 2019-2032 (US Million)
9. Global Antithrombin Market, By Region, 2019-2032 (US Million)
10. North America Antithrombin Market, By Source, 2019-2032 (US Million)
11. North America Antithrombin Market, By Application, 2019-2032 (US Million)
12. U.S. Antithrombin Market, By Source, 2019-2032 (US Million)
13. U.S. Antithrombin Market, By Application, 2019-2032 (US Million)
14. Canada Antithrombin Market, By Source, 2019-2032 (US Million)
15. Canada Antithrombin Market, By Application, 2019-2032 (US Million)
16. Mexico Antithrombin Market, By Source, 2019-2032 (US Million)
17. Mexico Antithrombin Market, By Application, 2019-2032 (US Million)
18. Europe Antithrombin Market, By Source, 2019-2032 (US Million)
19. Europe Antithrombin Market, By Application, 2019-2032 (US Million)
20. Germany Antithrombin Market, By Source, 2019-2032 (US Million)
21. Germany Antithrombin Market, By Application, 2019-2032 (US Million)
22. France Antithrombin Market, By Source, 2019-2032 (US Million)
23. France Antithrombin Market, By Application 2019-2032 (US Million)
24. U.K. Antithrombin Market, By Source, 2019-2032 (US Million)
25. U.K. Antithrombin Market, By Application 2019-2032 (US Million)
26. Italy Antithrombin Market, By Source, 2019-2032 (US Million)
27. Italy Antithrombin Market, By Application 2019-2032 (US Million)
28. Spain Antithrombin Market, By Source, 2019-2032 (US Million)
29. Spain Antithrombin Market, By Application 2019-2032 (US Million)
30. Asia Pacific Antithrombin Market, By Source, 2019-2032 (US Million)
31. Asia Pacific Antithrombin Market, By Application 2019-2032 (US Million)
32. Japan Antithrombin Market, By Source, 2019-2032 (US Million)
33. Japan Antithrombin Market, By Application 2019-2032 (US Million)
34. China Antithrombin Market, By Source, 2019-2032 (US Million)
35. China Antithrombin Market, By Application 2019-2032 (US Million)
36. India Antithrombin Market, By Source, 2019-2032 (US Million)
37. India Antithrombin Market, By Application 2019-2032 (US Million)
38. South America Antithrombin Market, By Source, 2019-2032 (US Million)
39. South America Antithrombin Market, By Application 2019-2032 (US Million)
40. Brazil Antithrombin Market, By Source, 2019-2032 (US Million)
41. Brazil Antithrombin Market, By Application 2019-2032 (US Million)
42. Middle East and Africa Antithrombin Market, By Source, 2019-2032 (US Million)
43. Middle East and Africa Antithrombin Market, By Application 2019-2032 (US Million)
44. UAE Antithrombin Market, By Source, 2019-2032 (US Million)
45. UAE Antithrombin Market, By Application 2019-2032 (US Million)
46. South Africa Antithrombin Market, By Source, 2019-2032 (US Million)
47. South Africa Antithrombin Market, By Application 2019-2032 (US Million)
List of Figures
1. Global Antithrombin Market Segmentation
2. Global Antithrombin Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Antithrombin Market Attractiveness Analysis By Source
9. Global Antithrombin Market Attractiveness Analysis By Application
10. Global Antithrombin Market Attractiveness Analysis By Region
11. Global Antithrombin Market: Dynamics
12. Global Antithrombin Market Share By Source (2023 & 2032)
13. Global Antithrombin Market Share By Application (2023 & 2032)
14. Global Antithrombin Market Share By Regions (2023 & 2032)
15. Global Antithrombin Market Share By Company (2022)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.